| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/10/2004 | US20040110752 2-amino-5-((hetero)aryl)-thiazole derivatives; treatment of disorders such as cancer, immunologic disorders and allergic disorders, optionally in combination with other drugs such as immunosuppressants |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110743 Aromatic amine or amide derivatives; neurodegenerative, brain, cardiovascular disorders; spinal cord injuries, encephalitis, cerebral palsy; cognition activators |
| 06/10/2004 | US20040110740 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-(hydroxymethyl)-3,3-dimethyl-7-oxo-, -1-(benzoyloxy)-alkyl ester, 4,4-dioxide derivative or solvate; can be mixed with beta-lactam antibiotic |
| 06/10/2004 | US20040110736 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110725 Pyridazines as interleukin-1beta converting enzyme inhibitors |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040110718 Anti-HCV nucleoside derivatives |
| 06/10/2004 | US20040110707 Method of treating neurological diseases |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110687 Administering immunomodulatory peptides for side effect reduction from cancer chemotherapy or radiotherapy; diarrhea, mucositis, stomatitis and proctitis |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110662 Administering cytotoxic agent and heat shock protein 90 inhibitors such as ansamycins for synergistic growth inhibitors of cells. This therapy as cytotoxic agent and as cell growth inhibitors |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109907 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | US20040109890 Tablets quickly disintegrated in oral cavity |
| 06/10/2004 | US20040109880 Cosmetic and/or pharmaceutical preparations |
| 06/10/2004 | US20040109867 Prodrugs of CC-1065 analogs |
| 06/10/2004 | US20040109865 Antibody composition-containing medicament |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | US20040109846 Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 06/10/2004 | US20040108086 Using Ecteinascidin- 743 drug alone or as part of synergistic mixture |
| 06/10/2004 | CA2507026A1 Imidazole derivatives, their production and use |
| 06/10/2004 | CA2498566A1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 06/09/2004 | EP1426443A1 Novel human bmcc1 gene |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426374A1 Naphthyridine derivative |
| 06/09/2004 | EP1426373A1 Method for producing the anticholinergic agent tiotropium bromide |
| 06/09/2004 | EP1426366A1 Thiazolidine derivative and medicinal use thereof |
| 06/09/2004 | EP1426360A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 06/09/2004 | EP1426060A1 Remedies for allergic diseases |
| 06/09/2004 | EP1426054A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1425409A2 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 06/09/2004 | EP1425390A2 Materials and methods to promote repair of nerve tissue |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425305A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425283A1 Novel 4-aminofuropyrimidines and the use thereof |
| 06/09/2004 | EP1425281A1 Chemical compounds |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425279A2 Method for the preparation of crystalline tetrahydrobenzothiepines |
| 06/09/2004 | EP1425277A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/09/2004 | EP1425264A1 C2-disubstituted indane-1-ol systems, method for their production and their use as medicaments |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425256A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 06/09/2004 | EP1425043A1 Method of increasing the presence of glutathione in cells |
| 06/09/2004 | EP1425041A2 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 06/09/2004 | EP1425034A1 Method for treating coumarin-induced hemorrhage |
| 06/09/2004 | EP1425032A2 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425018A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof |
| 06/09/2004 | EP1425016A2 Compositions and methods of treatment of cancer |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425009A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 06/09/2004 | EP1425007A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1425005A1 Pharmaceutical compostion comprising lumiracoxib |
| 06/09/2004 | EP1425003A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/09/2004 | EP1425002A1 Aryloxypropylamines as chemosensitizing agents in the treatment of cancer |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424996A1 Method for the production of inhalation powders |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1337535B1 Benzodiazepine derivatives as gaba a receptor modulators |
| 06/09/2004 | EP1326631B1 Botulinumtoxin for treating endocrine disorders |
| 06/09/2004 | EP1299380B1 Indole derivatives useful for the treatment of cns disorders |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1240137B1 Method for making 24(s)-hydroxyvitamin d 2 |
| 06/09/2004 | EP1202966B1 Piperidine alcohols |
| 06/09/2004 | EP1196412B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 06/09/2004 | EP1196176B1 Use of beta-napthoquinone derivatives for the manufacture of a medicament having an inhibiting effect on the release of glutamate by the brain |
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | EP1007504B1 Sterilized 5-aminolevulinic acid |
| 06/09/2004 | EP1000039B1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors |
| 06/09/2004 | EP0980366B1 Antithrombotic agents |
| 06/09/2004 | DE19534745B4 Verfahren zur Herstellung von 6-Hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophen Thiophene process for the preparation of 6-hydroxy-2- (4-hydroxyphenyl) -3- [4- (2-piperidinoethoxy) benzoyl] benzo [b] |
| 06/09/2004 | DE10320603A1 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503797A Pyridopyrimidine or naphthyridine derivative |
| 06/09/2004 | CN1503794A Inhiitors of cyclin dependent kinases as anti-cancer agent |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503790A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/09/2004 | CN1503787A Novel compounds |
| 06/09/2004 | CN1503786A Large conductance calcium-activated k channel opener |